|
US6297232B1
(en)
|
1996-12-20 |
2001-10-02 |
Astrazeneca Ab |
Triazolo[4,5-D]pyrimidinyl derivatives and their use as medicaments
|
|
AR017014A1
(es)
*
|
1997-07-22 |
2001-08-22 |
Astrazeneca Ab |
Compuestos de triazolo [4,5-d]pirimidina, composiciones farmaceuticas, uso de los mismos para preparar medicamentos y procesos para la preparacionde dichos compuestos
|
|
SE9702772D0
(sv)
*
|
1997-07-22 |
1997-07-22 |
Astra Pharma Prod |
Novel compounds
|
|
SE9702774D0
(sv)
*
|
1997-07-22 |
1997-07-22 |
Astra Pharma Prod |
Novel compounds
|
|
SE9702773D0
(sv)
|
1997-07-22 |
1997-07-22 |
Astra Pharma Prod |
Novel compounds
|
|
TR200002380T2
(tr)
|
1998-02-17 |
2001-03-21 |
Astrazeneca Uk Limited |
Yeni triazolo (4,5-d) pirimidin bileşikleri
|
|
SE9802574D0
(sv)
*
|
1998-07-17 |
1998-07-17 |
Astra Pharma Prod |
Novel compounds
|
|
TWI229674B
(en)
|
1998-12-04 |
2005-03-21 |
Astra Pharma Prod |
Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
|
|
SE9904129D0
(sv)
|
1999-11-15 |
1999-11-15 |
Astra Pharma Prod |
Novel compounds
|
|
SE9904128D0
(sv)
*
|
1999-11-15 |
1999-11-15 |
Astra Pharma Prod |
Novel compounds
|
|
SE9904377D0
(sv)
*
|
1999-12-01 |
1999-12-01 |
Astra Pharma Prod |
Pharmaceutical combinations
|
|
GB0013407D0
(en)
|
2000-06-02 |
2000-07-26 |
Astrazeneca Ab |
Forms of a chemical compound
|
|
GB0013488D0
(en)
*
|
2000-06-02 |
2000-07-26 |
Astrazeneca Ab |
Chemical compound
|
|
AR039558A1
(es)
*
|
2000-08-21 |
2005-02-23 |
Inspire Pharmaceuticals Inc |
Composiciones y metodo para el tratamiento de glaucoma o hipertension ocular
|
|
US7115585B2
(en)
*
|
2000-08-21 |
2006-10-03 |
Inspire Pharmaceuticals, Inc. |
Compositions for treating epithelial and retinal tissue diseases
|
|
US7018985B1
(en)
|
2000-08-21 |
2006-03-28 |
Inspire Pharmaceuticals, Inc. |
Composition and method for inhibiting platelet aggregation
|
|
US7132408B2
(en)
*
|
2000-08-21 |
2006-11-07 |
Inspire Pharmaceuticals, Inc. |
Composition and method for inhibiting platelet aggregation
|
|
US7452870B2
(en)
|
2000-08-21 |
2008-11-18 |
Inspire Pharmaceuticals, Inc. |
Drug-eluting stents coated with P2Y12 receptor antagonist compound
|
|
US6897201B2
(en)
*
|
2000-08-21 |
2005-05-24 |
Inspire Pharmaceuticals, Inc. |
Compositions and methods for the treatment of glaucoma or ocular hypertension
|
|
GB0100624D0
(en)
*
|
2001-01-10 |
2001-02-21 |
Vernalis Res Ltd |
Chemical compounds VII
|
|
SE0101932D0
(sv)
*
|
2001-05-31 |
2001-05-31 |
Astrazeneca Ab |
Pharmaceutical combinations
|
|
US20020169730A1
(en)
*
|
2001-08-29 |
2002-11-14 |
Emmanuel Lazaridis |
Methods for classifying objects and identifying latent classes
|
|
US7435724B2
(en)
|
2002-02-27 |
2008-10-14 |
Inspire Pharmaceutical, Inc. |
Degradation-resistant mononucleoside phosphate compounds
|
|
US20080070932A1
(en)
*
|
2003-04-09 |
2008-03-20 |
Chi Vu |
Triazolo[
1,5-A]
Pyrimidines And Pyrazolo[
1,5-A]
Pyrimidines And Methods Of Making And Using The Same
|
|
WO2004092172A2
(en)
*
|
2003-04-09 |
2004-10-28 |
Biogen Idec Ma Inc. |
Triazolo[1,5-c]pyrimidines and pyrazolo[1,5-c]pyrimidines useful as a2a adenosin e receptor antagonists
|
|
WO2004092173A2
(en)
*
|
2003-04-09 |
2004-10-28 |
Biogen Idec Ma Inc. |
A2a adenosine receptor antagonists
|
|
WO2004092170A2
(en)
*
|
2003-04-09 |
2004-10-28 |
Biogen Idec Ma Inc. |
Triazolotriazines and pyrazolotriazines useful as a2a adenosine receptor antagon ists
|
|
WO2004092177A1
(en)
*
|
2003-04-09 |
2004-10-28 |
Biogen Idec Ma Inc. |
Triazolopyrazines and methods of making and using the same
|
|
US7749981B2
(en)
*
|
2003-10-21 |
2010-07-06 |
Inspire Pharmaceuticals, Inc. |
Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound
|
|
JP2007509180A
(ja)
*
|
2003-10-21 |
2007-04-12 |
インスパイアー ファーマシューティカルズ，インコーポレイティド |
疼痛を治療するための、非ヌクレオチド組成物および方法
|
|
JP2007514647A
(ja)
*
|
2003-10-21 |
2007-06-07 |
インスパイアー ファーマシューティカルズ，インコーポレイティド |
テトラヒドロ−フロ［３，４−ｄ］ジオキソール化合物並びに血小板凝集を阻害する組成物及び方法
|
|
US7335648B2
(en)
*
|
2003-10-21 |
2008-02-26 |
Inspire Pharmaceuticals, Inc. |
Non-nucleotide composition and method for inhibiting platelet aggregation
|
|
US7504497B2
(en)
*
|
2003-10-21 |
2009-03-17 |
Inspire Pharmaceuticals, Inc. |
Orally bioavailable compounds and methods for inhibiting platelet aggregation
|
|
US7932376B2
(en)
|
2005-05-05 |
2011-04-26 |
Inspire Pharmaceuticals, Inc. |
Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation
|
|
JP2010508350A
(ja)
|
2006-10-31 |
2010-03-18 |
ヤンセン ファーマシューティカ エヌ．ベー． |
Ａｄｐｐ２ｙ１２レセプターアンタゴニストとしてのトリアゾロピリミジン誘導体
|
|
UA100864C2
(uk)
*
|
2007-12-03 |
2013-02-11 |
Астразенека Аб |
Спосіб лікування або запобігання аневризмі черевної аорти
|
|
GB0906579D0
(en)
|
2009-04-16 |
2009-05-20 |
Vernalis R&D Ltd |
Pharmaceuticals, compositions and methods of making and using the same
|
|
US8470834B2
(en)
*
|
2008-08-20 |
2013-06-25 |
Merck Sharp & Dohme Corp. |
AZO-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
|
|
EP2536695A1
(en)
|
2010-02-16 |
2012-12-26 |
Actavis Group Ptc Ehf |
Improved processes for preparing ticagrelor intermediate, 4,6-dichloro-5-nitro-2-(propylthio)pyrimidine
|
|
US20150329546A1
(en)
|
2011-11-30 |
2015-11-19 |
Actavis Group Ptc Ehf |
Novel crystalline form of ticagrelor and process for the preparation thereof
|
|
WO2014083139A1
(en)
|
2012-11-29 |
2014-06-05 |
Actavis Group Ptc Ehf |
Novel amorphous form of ticagrelor
|
|
WO2014206187A1
(zh)
|
2013-06-24 |
2014-12-31 |
苏州明锐医药科技有限公司 |
替卡格雷及其中间体的制备方法
|
|
JP6145574B2
(ja)
*
|
2013-06-27 |
2017-06-14 |
スーヂョウ ミラクファーマ テクノロジ カンパニー リミテッドＳｕｚｈｏｕ Ｍｉｒａｃｐｈａｒｍａ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏ．，Ｌｔｄ． |
チカグレロールの調製方法
|
|
CN105061431B
(zh)
*
|
2015-07-28 |
2017-03-29 |
山东百诺医药股份有限公司 |
6‑n‑（2‑（甲硫基）乙基）‑2‑（（3,3,3‑三氟丙基）硫代）‑9h‑嘌呤及其制备方法和应用
|
|
CN112876485A
(zh)
*
|
2021-01-25 |
2021-06-01 |
郭丽伟 |
一种用于治疗子宫平滑肌高频率强直性收缩相关疾病的化合物
|
|
CN112915063B
(zh)
*
|
2021-01-25 |
2022-12-20 |
刘红枚 |
一种用于治疗子宫平滑肌高频率强直性收缩相关疾病的化合物
|
|
RU2770405C1
(ru)
*
|
2021-07-05 |
2022-04-15 |
федеральное государственное бюджетное образовательное учреждение высшего образования "Башкирский государственный медицинский университет" Министерства здравоохранения Российской Федерации |
Производные триазола, проявляющие антиагрегационную активность
|